Skip to content

Advertisement

Open Access

Comparative analysis of choroidal thickness in third trimester pregnant women

International Journal of Retina and Vitreous20184:6

https://doi.org/10.1186/s40942-018-0108-0

Received: 4 September 2017

Accepted: 9 January 2018

Published: 29 January 2018

Abstract

Background

The impact of pregnancy on the choroid is still under investigation. The aim of this study is to compare choroidal thickness measurements of healthy pregnant women in the third trimester and healthy non-pregnant women using spectral-domain optical coherence tomography (OCT).

Methods

This cross-sectional study included 122 eyes of 61 women, divided into two groups: 27 healthy pregnant women in the third trimester and 34 age-matched healthy non-pregnant women. Choroidal thickness was measured using Enhanced Depth Imaging OCT at ten different locations: at the fovea and every 500 µm from the fovea up to 2500 µm temporally and up to 2000 µm nasally.

Results

There were no significant differences in the ten measurements of choroidal thickness comparing both groups. Mean subfoveal choroidal thickness was 304.1 + 9.6 µm in the control group and 318.1 + 15.6 µm in the pregnant women group (p = 0.446). There was also no statistically significant association between gestational age and choroidal thickness measurements in the healthy pregnant women group.

Conclusions

Our study showed no statistically difference in choroidal thickness between healthy non-pregnant women and healthy pregnant women in the third trimester.

Keywords

Choroidal thicknessEnhanced depth imaging optical coherence tomographyPregnancyChoroid

Background

Physiological changes during pregnancy are significant and their knowledge is essential to optimize outcomes. Volemia augmentation in pregnancy averages 40–45% above the nonpregnant blood volume after 32–34 weeks. Cardiac output is increased as early as the 5th week and reflects a reduced systemic vascular resistance and an increased heart rate [13].

Ocular changes during pregnancy like an increased central corneal thickness and curvature and decreased corneal sensitivity and intraocular pressure (IOP) were already described [4, 5]. Changes in ocular blood flow may also occur, as an increased pulsatile ocular blood flow [6].

The impact of pregnancy on the choroid, however, is still under investigation, with mixed results. A strong association of central serous chorioretinopathy and pregnancy is well documented [7, 8]. Choroidal dysfunction and ischemia are also a common ocular complication of preeclampsia [9].

The development of the enhanced depth imaging (EDI) technique of spectral-domain optical coherence tomography (SD-OCT) systems allowed analysis of choroidal morphologic features in normal and pathological eyes [10]. EDI-OCT promotes better documentation of the choroid and choroidal–scleral interface by decreasing signal strength posterior to the retinal pigment epithellium. Since it is a noninvasive diagnostic method, EDI-OCT would be ideal for the study of choroid changes during an uncomplicated pregnancy.

The aim of this study was to compare choroidal thickness measurements of healthy women, pregnant and non-pregnant, using EDI-OCT.

Methods

This cross-sectional study included 122 eyes of 61 women, divided into two groups: 27 healthy pregnant women in the third trimester and 34 age-matched healthy non-pregnant women. The participants were recruited between March and September of 2016 at Hospital de Clinicas de Porto Alegre (HCPA), Brazil. All participants received in person full explanation about the study and provided written informed consent. This study was approved by HCPA research ethics committee and was conducted in accordance with the Declaration of Helsinki guidelines.

Participants underwent an interview with demographic and background history and complete ophthalmic examination. Subjects with any previous ocular surgery or ocular pathology including refractive disorders with spherical equivalent greater than ± 1.0 diopters were excluded. All pregnant women enrolled in the study were attending prenatal care and were having uneventful singleton pregnancy. Participants with history of smoking or diagnosed with any systemic disease, such as diabetes mellitus, hypertension, preeclampsia, renal, rheumatologic or cardiovascular diseases, were also excluded.

All OCT scans were performed in the morning (8:00 am to 12:00 pm) to avoid diurnal variations of choroidal thickness [11, 12]. The same experienced ophthalmologist (CB) performed all OCT scans, using Heidelberg Spectralis OCT (Heidelberg Engineering Co, Heidelberg, Germany). Choroid was imaged with a 6-line radial scan (30°, 9.2 mm) using EDI setting, with 100 images averaged per section. All scans were reviewed before their inclusion in the study; those with image artefacts or inaccurate choroidal limits were excluded. Only one single horizontal scan through the fovea was used for analysis.

Choroidal thickness was determined as the vertical distance from the outer surface of the line formed by the retinal pigment epithelium to the chorioscleral interface using the Spectralis OCT measurement software. The measurements were made by an experienced ophthalmologist (DL) masked to the participant group. Previous studies have already demonstrated the reproducibility of choroidal thickness measurements, even across different OCT systems [1315]. Choroidal thickness was measured at ten different locations: at the fovea and every 500 µm from the fovea up to 2500 µm temporally and up to 2000 µm nasally (Fig. 1). We used the following abbreviations for the macular points: T5: choroidal thickness at 2500 µm temporally to the fovea; T4: choroidal thickness at 2000 µm temporally to the fovea; T3: choroidal thickness at 1500 µm temporally to the fovea; T2: choroidal thickness at 1000 µm temporally to the fovea; T1: choroidal thickness at 500 µm temporally to the fovea; SF: choroidal thickness at the fovea; N1: choroidal thickness at 500 µm nasally to the fovea; N2: choroidal thickness at 1000 µm nasally to the fovea; N3: choroidal thickness at 1500 µm nasally to the fovea; N4: choroidal thickness at 2000 µm nasally to the fovea.
Figure 1
Fig. 1

Measurements of choroidal thickness. Choroidal thickness measured at ten different locations: at the fovea and every 500 µm from the fovea up to 2500 µm temporally and up to 2000 µm nasally

Statistical analysis

Statistical analyses were performed using SPSS V.15.0 (SPSS Science, Chicago, Illinois, USA). Quantitative variables from sample demographics were presented as mean ± SD. To compare variables between groups a t test was used for quantitative data and a Fisher’s exact test for qualitative data. Choroidal thickness measures were presented as mean ± SE. Differences in choroidal thickness were analysed using generalized estimating equations (GEE) with Bonferroni adjustment. Pearson’s correlation was used to analyze the relationship between choroidal thickness and gestational age. A p value ≤ 0.05 was considered statistically significant.

Results

This study included 68 eyes of 34 healthy non-pregnant women (Control Group) and 54 eyes of 27 healthy pregnant women in the third trimester (Pregnant Group). Mean age of non-pregnant and pregnant women was 26.8 ± 5.0 and 28.1 ± 7.0 years, respectively (p = 0.439; t test). Racial distribution included 31 (91.2%) caucasians and 3 (8.8%) african-american in control group and 25 (92.6%) caucasians and 2 (7.4%) african-american in pregnant group (p = 1.000; Fisher’s exact test). The mean gestational age in the pregnant group was 33.3 ± 2.6 weeks.

The OCT scans were performed in all 54 eyes of the 27 healthy pregnant women and in all 68 eyes of the 34 healthy non-pregnant women. There were no significant differences in the ten measurements of choroidal thickness across the groups. (Table 1) Mean subfoveal choroidal thickness was 304.1 + 9.6 µm in the control group and 318.1 + 15.6 µm in the pregnant group (p = 0.446).
Table 1

Choroidal thickness measurements of healthy pregnant women in the third trimester and control group

 

Control group

Pregnant group

p value

Mean + SE (µm)

Mean + SE (µm)

T5

277.4 + 9.6

278.5 + 13.9

0.949

T4

284.8 + 10.1

291.5 + 15.2

0.716

T3

292.1 + 9.8

300.9 + 14.3

0.611

T2

301.7 + 8.9

308.2 + 14.8

0.708

T1

299.1 + 8.6

311.2 + 14.8

0.478

SF

304.1 + 9.6

318.1 + 15.6

0.446

N1

285.1 + 9.6

291.3 + 14.9

0.730

N2

270.3 + 10.6

267.1 + 14.7

0.860

N3

245.6 + 10.9

239.4 + 13.9

0.725

N4

213.5 + 11.5

210.2 + 12.2

0.843

GEE with Bonferroni adjustment

T5: choroidal thickness at 2500 µm temporally to the fovea; T4: choroidal thickness at 2000 µm temporally to the fovea; T3: choroidal thickness at 1500 µm temporally to the fovea; T2: choroidal thickness at 1000 µm temporally to the fovea; T1: choroidal thickness at 500 µm temporally to the fovea; SF: choroidal thickness at the fovea; N1: choroidal thickness at 500 µm nasally to the fovea; N2: choroidal thickness at 1000 µm nasally to the fovea; N3: choroidal thickness at 1500 µm nasally to the fovea; N4: choroidal thickness at 2000 µm nasally to the fovea

We also analyzed if there was any correlation between the choroidal thickness measurements of both eyes and the gestational week in the third trimester of gestation using Pearson’s correlation. There was no statistically significant association between the gestational week and choroidal thickness measurements of both eyes in healthy pregnant women in the third trimester (Table 2).
Table 2

Correlation of gestational week and choroidal thickness measurements of both eyes in third trimester healthy pregnancies

 

Pearson correlation coeficiente (r)

p value

T5

 OD

− 0.345

0.085

 OS

− 0.202

0.322

T4

 OD

− 0.228

0.263

 OS

− 0.167

0.414

T3

 OD

− 0.234

0.250

 OS

− 0.093

0.650

T2

 OD

− 0.223

0.274

 OS

− 0.073

0.723

T1

 OD

− 0.200

0.327

 OS

− 0.141

0.492

SF

 OD

− 0.193

0.345

 OS

− 0.213

0.295

N1

 OD

− 0.237

0.243

 OS

− 0.216

0.289

N2

 OD

− 0.199

0.330

 OS

− 0.180

0.378

N3

 OD

− 0.144

0.482

 OS

− 0.149

0.468

N4

 OD

− 0.089

0.665

 OS

− 0.143

0.487

T5: choroidal thickness at 2500 µm temporally to the fovea; T4: choroidal thickness at 2000 µm temporally to the fovea; T3: choroidal thickness at 1500 µm temporally to the fovea; T2: choroidal thickness at 1000 µm temporally to the fovea; T1: choroidal thickness at 500 µm temporally to the fovea; SF: choroidal thickness at the fovea; N1: choroidal thickness at 500 µm nasally to the fovea; N2: choroidal thickness at 1000 µm nasally to the fovea; N3: choroidal thickness at 1500 µm nasally to the fovea; N4: choroidal thickness at 2000 µm nasally to the fovea

Discussion

The choroid is a complex vascular network which provides vascular supply for the retinal pigment epithelium and outer retina layers. It also provides thermal stability for the ocular tissues, removes ocular waste and acts in the uveoscleral aqueous drainage and regulation of intraocular pressure [4, 16]. Choroidal circulation is characterized by a high blood flow controlled by autonomic innervation, while retinal blood flow is mainly determined by autoregulatory mechanisms and local factors [17]. This vascular network is responsible for more than 85% of the blood flow in the eye and it can be influenced by hemodynamic factors such as blood flow and perfusion pressure [18].

Pregnancy itself promotes metabolic, hormonal and hemodynamic changes which could lead to changes in choroidal blood flow. During pregnancy there is an expansion of blood volume up to 45%, an increase in cardiac output and renin and angiotensin levels, and a decrease in colloid osmotic pressure, vascular resistance and arterial blood pressure [1, 3]. There are also some conditions such as central serous chorioretinopathy (CSC) which has an increased prevalence during pregnancy, especially in the third trimester [7, 19]. Previous studies have shown that patients with CSC have thickening of choroid when compared to controls [20, 21]. Choroidal vasodilation and vascular hyperpermeability can cause subsequent vascular leakage and increased hydrostatic pressure in the choroid. The high plasma cortisol concentration may also be a contributor for CSC development in pregnancy. All considered, it is essential to ask whether pregnancy itself can change choroidal structure and thickness.

Traditional imaging modalities such as indocyanine green angiography and Doppler ultrasonography were used in the past to assess choroidal function during pregnancy [9, 22]. The development of EDI-OCT, however, provided a fast, noninvasive and safe method to analyze choroidal thickness. Choroidal thickness can be influenced by major factors such as age, refractive error and axial length (AL), with increasing age, AL and decreasing refractive diopter being associated with a reduction of choroidal thickness [23]. Previous authors have measured choroidal thickness during pregnancy, with conflicting results [16, 2432]. Different methodology may justify these different results. Table 3 summarizes results of different studies comparing choroidal thickness measurements of healthy pregnant and non-pregnant women using EDI-OCT.
Table 3

Summarized results of different studies comparing choroidal thickness measurements of healthy pregnant and non-pregnant women using EDI-OCT

References

Subjects

Gestational age at exam

Mean subfoveal choroidal thickness (SFCT)

Conclusion

Takahashi et al. [27]

30 pregnant women

30 non-pregnant women

Third trimester

275 ± 84 µm

273 ± 92 µm

No significant difference in choroidal thickness between groups (p = 0.925)

Sayin et al. [25]

46 pregnant women

40 non-pregnant women

Variable

28.0 ± 5.8 weeks

(range: 17–37 weeks)

368.6 ± 67.6 µm

334.8 ± 59.9 µm

SFCT in normal pregnant women was significantly thicker than in non-pregnant healthy women (p = 0.038)

Kara et al. [24]

100 pregnant women

100 non-pregnant women

Variable

27.3 ± 6.6 weeks

(range: 15–38 weeks)

371.1 ± 61.8 µm

337.2 ± 62.4 µm

SFCT in normal pregnant women was significantly thicker than in non-pregnant healthy women (p < 0.01)

Atas et al. [26]

25 pregnant women

26 non-pregnant women

Over 28 weeks

387.2 ± 60.76 µm

322.35 ± 63.89 µm

SFCT in normal pregnant women was significantly thicker than in non-pregnant healthy women (p < 0.001)

Goktas et al. [29]

30 pregnant women in the first trimester

30 pregnant women in the second trimester

30 pregnant women in the third trimester

30 non-pregnant women

First trimester

Second trimester

Third trimester

362 ± 81 µm

395 ± 80 µm

368 ± 70 µm

335 ± 86 µm

SFCT was significantly thicker in pregnant women in the second trimester (p = 0.007)

Ulusoy et al. [16]

29 pregnant women

36 non-pregnant women

Third trimester

3 months after delivery

387.97 ± 59.91 µm

332.40 ± 26.02 µm

320.86 ± 59.18 µm

SFCT significantly increases during pregnancy and returns to normal range 3 months after delivery

Kim et al. [21]

14 pregnant women

21 non-pregnant women

Third trimester

274.23 ± 29.30 µm

264.95 ± 21.03 µm

No significant difference in choroidal thickness between groups (p = 0.325)

Dadaci et al. [30]

27 pregnant women

25 non-pregnant women

First trimester

Third trimester

OD: 349.22 ± 82.11 µm

OE: 341.30 ± 85.22 µm

OD: 333.56 ± 76.61 µm

OE: 326.93 ± 75.84 µm

OD: 318.88 ± 53.13 µm

OE: 310.60 ± 51.09 µm

Choroidal thickness measurements in the third trimester were significantly decreased in both eyes compared to first trimester measurements

Rothwell et al. [31]

12 pregnant women

12 non-pregnant women

Third trimester

319.58 ± 6.11 µm

287.58 ± 43.44 µm

Choroidal thickness in normal pregnant women was significantly thicker than in non-pregnant healthy women (p = 0.034)

Acmaz et al. [32]

24 pregnant women

38 non-pregnant women

After 24 weeks

393.77 ± 61.83 µm

322.49 ± 65.58 µm

Choroidal thickness in normal pregnant women was significantly thicker than in non-pregnant healthy women (p < 0.001)

Kara et al. [24], Sayin et al. [25] and Atas et al. [26] conducted studies comparing choroidal thickness of healthy pregnant women in different gestational ages with healthy non-pregnant women. The authors concluded that subfoveal choroid was significantly thicker in pregnant women. However, other studies did not find this difference in choroid thickness. Takahashi et al. [27] and Kim et al. [28] demonstrated that choroidal thickness was not significantly different when comparing pregnant women in their third trimester and healthy non-pregnant women.

Other authors attempted to evaluate choroidal thickness considering gestational age. Goktas et al. [29] conducted a study with 90 healthy pregnant women, 30 at each pregnancy trimester, and 30 non-pregnant healthy women. Choroidal was significantly thicker in second trimester pregnant women in comparison with non-pregnant women. Dadaci et al. [30] compared choroidal thickness measurements of 54 eyes of 27 healthy pregnant women with 50 eyes of 25 non-pregnant women. The pregnant women underwent two OCT scans, one in the first trimester and the other in the third trimester. Choroidal thickness was significantly decreased at all measured points during the third trimester compared to the first trimester. The measurements of the control group were not statistically different.

Ulusoy et al. [16] conducted a prospective study to analyze choroidal thickness in third trimester pregnant women and 3 months after delivery. The subfoveal choroidal thickness was significantly reduced after delivery. A different control group of non-pregnant women was also analyzed and showed significantly thinner choroid measurements in comparison with pregnant women. Rothwell et al. [31] used a different technique to analyze choroid structure by constructing volume macular maps for the 9 subfields defined by the Early Treatment Diabetic Retinopathy Study. The measurements of thickness and volume in the central subfield were significantly greater in third trimester pregnant patients than in non-pregnant patients.

In this study, there were no significant differences in choroidal thickness among the two groups in ten macular points. We also found no significant correlation between choroid thickness and gestational age. These findings did not confirm our initial hypothesis that choroid could be thicker at pregnancy by an overall increase in choroidal blood flow and a decrease in intraocular pressure. However, the results of other studies about choroidal thickness during uncomplicated pregnancy are conflicting, and our findings are similar to those of Takahashi [27] and Kim [28].

Our study has some limitations, such as the small number of subjects. In addition, the cross-sectional design allow us to analyze choroid characteristics only in the third trimester of pregnancy, which could explain our lack of difference, since some authors described thicker choroids specifically at first or second trimesters. More consistent results could be achieved with a longitudinal study of choroidal thickness during the three trimesters of pregnancy and postpartum period with a large number of subjects.

In conclusion, our study reinforces absence of statistical difference in choroidal thickness between healthy third trimester pregnant women and healthy non-pregnant women. Further prospective studies with a larger number of subjects should be performed during different gestational ages and also after delivery.

Declarations

Authors’ contributions

CZB participated of the conception, acquisition and analysis of data and drafting of the manuscript. TZ contributed selecting subjects from prenatal care. LBF assisted in the ophthalmological exams. MLRO, LHC and DL analyzed and interpreted the patient data and contributed in writing the manuscript. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors report no conflicts of interests.

Consent for publication

Consent for publication was obtained from the participant whose OCT image was used for Fig. 1.

Ethics approval and consent to participate

All participants received in person full explanation about the study and provided written informed consent. This study was approved by Hospital de Clinicas de Porto Alegre research ethics committee (CAAE 33897314.1.0000.5327) and was conducted in accordance with the Declaration of Helsinki guidelines.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
(2)
Department of Ophthalmology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
(3)
Department of Gynecology and Obstetrics, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
(4)
Department of Endocrinology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

References

  1. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol. 2000;24(1):11–4.View ArticlePubMedGoogle Scholar
  2. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:1060–5.Google Scholar
  3. Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv. 1994;49:1–14.View ArticleGoogle Scholar
  4. Zhang J, Wang H, Yu Q, Tong Q, Lu Q. Enhanced depth imaging optical coherence tomography: a new way measuring choroidal thickness in pregnant women. J Ophthalmol. 2017;2017:1–9.Google Scholar
  5. Weinreb R, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol. 1988;105(3):258–60.View ArticlePubMedGoogle Scholar
  6. Centofanti M, Manni G, Migliardi R, Zarfati D, Lorenzano D, Scipioni M, et al. Influence of pregnancy on ocular blood flow. Acta Ophthalmol Scand. 2002;80(s236):52–3.View ArticleGoogle Scholar
  7. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111:244–9.View ArticlePubMedGoogle Scholar
  8. Kuroda S, Ikuno Y, Yasuno Y, Nakai K, Usui S, Sawa M, et al. Choroidal thickness in central serous chorioretinopathy. Retina. 2013;33(2):302–8.View ArticlePubMedGoogle Scholar
  9. Valluri S, Adelberg DA, Curtis RS, Olk RJ. Diagnostic indocyanine green angiography in preeclampsia. Am J Ophthalmol. 1996;122(5):672–7.View ArticlePubMedGoogle Scholar
  10. Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.View ArticlePubMedGoogle Scholar
  11. Tan C, Ouyang Y, Ruiz H, Sadda S. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(1):261.View ArticlePubMedGoogle Scholar
  12. Chakraborty R, Read S, Collins M. Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics. Invest Ophthalmol Vis Sci. 2011;52(8):5121.View ArticlePubMedGoogle Scholar
  13. Chhablani J, Barteselli G, Wang H, El-Emam S, Kozak I, Doede A, et al. Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(4):2274.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Branchini L, Regatieri C, Flores-Moreno I, Baumann B, Fujimoto J, Duker J. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology. 2012;119(1):119–23.View ArticlePubMedGoogle Scholar
  15. Koay C, Quo M, Subrayan V. Reproducibility of choroidal thickness measurements in subjects on 3 spectral domain optical coherence tomography machines. Int Ophthalmol. 2016;37(3):655–71.View ArticlePubMedGoogle Scholar
  16. Ulusoy DM, Duru N, Ataş M, Altınkaynak H, Duru Z, Açmaz G. Measurement of choroidal thickness and macular thickness during and after pregnancy. Int J Ophthalmol. 2015;8(2):321–5.PubMedPubMed CentralGoogle Scholar
  17. Delaey C, Van De Voorde J. Regulatory mechanisms in the retinal and choroidal circulation. Ophthalmic Res. 2000;32(6):249–56.View ArticlePubMedGoogle Scholar
  18. McDougal D, Gamlin P. Autonomic control of the eye. Compr Physiol. 2015;5(1):439–73.PubMedPubMed CentralGoogle Scholar
  19. Chatziralli I, Kabanarou S, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study. Curr Eye Res. 2017;42(7):1069–73.View ArticlePubMedGoogle Scholar
  20. Imamura Y, Fujiwara T, Margolis R, Spaide R. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469–73.View ArticlePubMedGoogle Scholar
  21. Kim Y, Kang S, Bai K. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy. Eye. 2011;25(12):1635–40.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Chaine G, Attali P, Gaudric A, Colin M, Quentel G, Coscas G. Ocular fluorophotometric and angiographic findings in toxemia of pregnancy. Arch Ophthalmol. 1986;104(11):1632–5.View ArticlePubMedGoogle Scholar
  23. Xiong S, He X, Deng J, Lv M, Jin J, Sun S, et al. Choroidal thickness in 3001 Chinese children aged 6 to 19 years using swept-source OCT. Sci Rep. 2017;7:450–9.View ArticleGoogle Scholar
  24. Kara N, Sayin N, Pirhan D, Vural A, Araz-Ersan H, Tekirdag A, et al. Evaluation of subfoveal choroidal thickness in pregnant women using enhanced depth imaging optical coherence tomography. Curr Eye Res. 2014;39(6):642–7.View ArticlePubMedGoogle Scholar
  25. Sayin N, Kara N, Pirhan D, Vural A, Araz Ersan H, Tekirdag A, et al. Subfoveal choroidal thickness in preeclampsia: comparison with normal pregnant and nonpregnant women. Semin Ophthalmol. 2014;29(1):11–7.View ArticlePubMedGoogle Scholar
  26. Ataş M, Açmaz G, Aksoy H, Demircan S, Ataş F, Gülhan A, et al. Evaluation of the macula, retinal nerve fiber layer and choroid in preeclampsia, healthy pregnant and healthy non-pregnant women using spectral-domain optical coherence tomography. Hypertens Pregnancy. 2014;33(3):299–310.View ArticlePubMedGoogle Scholar
  27. Takahashi J, Kado M, Mizumoto K, Igarashi S, Kojo T. Choroidal thickness in pregnant women measured by enhanced depth imaging optical coherence tomography. Jpn J Ophthalmol. 2013;57(5):435–9.View ArticlePubMedGoogle Scholar
  28. Kim J, Park M, Kim Y, Kim Y. Comparison of subfoveal choroidal thickness in healthy pregnancy and pre-eclampsia. Eye. 2015;30(3):349–54.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Goktas S, Basaran A, Sakarya Y, Ozcimen M, Kucukaydin Z, Sakarya R, et al. Measurement of choroid thickness in pregnant women using enhanced depth imaging optical coherence tomography. Arq Bras Oftalmol. 2014;77(3):148–51.View ArticlePubMedGoogle Scholar
  30. Dadaci Z, Alptekin H, Oncel Acir N, Borazan M. Changes in choroidal thickness during pregnancy detected by enhanced depth imaging optical coherence tomography. Br J Ophthalmol. 2015;99(9):1255–9.View ArticlePubMedGoogle Scholar
  31. Rothwell RT, Meira DM, Oliveira MA, Ribeiro LF, Fonseca SL. Evaluation of choroidal thickness and volume during the third trimester of pregnancy using enhanced depth imaging optical coherence tomography: a pilot study. J Clin Diagn Res. 2015;9(8):NC08–11.PubMedPubMed CentralGoogle Scholar
  32. Acmaz G, Atas M, Gulhan A, Acmaz B, Atas F, Aksoy H, et al. Assessment of macular peripapillary nerve fiber layer and choroidal thickness changes in pregnant women with gestational diabetes mellitus, healthy pregnant women, and healthy non-pregnant women. Med Sci Monit. 2015;21:1759–64.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement